Kymab Limited Patent Application Trends in 2024

Kymab Limited patent applications in 2024

Top 10 Technology Areas

• A61K39/3955 (No explanation available)
  • Count: 5 patents
  • Example: 20240122985. ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS simplified abstract (KYMAB LIMITED)
• A61K45/06 (No explanation available)
  • Count: 4 patents
  • Example: 20240122985. ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS simplified abstract (KYMAB LIMITED)
• A61K2039/505 (No explanation available)
  • Count: 4 patents
  • Example: 20240158502. ANTI-ICOS ANTIBODIES simplified abstract (Kymab Limited)
• C07K2317/52 (No explanation available)
  • Count: 3 patents
  • Example: 20240199755. ANTAGONISTS AND AGONISTS OF THE TRANSFERRIN RECEPTOR-2 FOR USE IN THE TREATMENT OF DISEASES OF THE BONE simplified abstract (Kymab Limited)
• C07K2317/76 (No explanation available)
  • Count: 3 patents
  • Example: 20240199755. ANTAGONISTS AND AGONISTS OF THE TRANSFERRIN RECEPTOR-2 FOR USE IN THE TREATMENT OF DISEASES OF THE BONE simplified abstract (Kymab Limited)
• C07K2317/56 (No explanation available)
  • Count: 3 patents
  • Example: 20240200054. METHODS, CELLS & ORGANISMS simplified abstract (Kymab Limited)
• C07K16/2875 (No explanation available)
  • Count: 2 patents
  • Example: 20240122985. ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS simplified abstract (KYMAB LIMITED)
• C07K16/2818 (No explanation available)
  • Count: 2 patents
  • Example: 20240158502. ANTI-ICOS ANTIBODIES simplified abstract (Kymab Limited)
• A61K39/395 (No explanation available)
  • Count: 2 patents
  • Example: 20240158502. ANTI-ICOS ANTIBODIES simplified abstract (Kymab Limited)
• A61P35/00 (No explanation available)
  • Count: 2 patents
  • Example: 20240158502. ANTI-ICOS ANTIBODIES simplified abstract (Kymab Limited)

Emerging Technology Areas

• A61P9/12 (No explanation available)
  • Count: 1 patents
  • Example: 20240026020. ANTI-OPG ANTIBODIES simplified abstract (KYMAB LIMITED)
• C07K16/2878 (No explanation available)
  • Count: 1 patents
  • Example: 20240026020. ANTI-OPG ANTIBODIES simplified abstract (KYMAB LIMITED)
• C07K2317/31 (No explanation available)
  • Count: 1 patents
  • Example: 20240190964. TREATMENT OF PD-L1 NEGATIVE OR LOW EXPRESSING CANCER WITH ANTI-ICOS ANTIBODIES simplified abstract (Kymab Limited)
• C07K2317/567 (No explanation available)
  • Count: 1 patents
  • Example: 20240057572. Animal Models and Therapeutic Molecules simplified abstract (Kymab Limited)
• C07K2317/565 (No explanation available)
  • Count: 1 patents
  • Example: 20240057572. Animal Models and Therapeutic Molecules simplified abstract (Kymab Limited)
• C07K2317/21 (No explanation available)
  • Count: 1 patents
  • Example: 20240057572. Animal Models and Therapeutic Molecules simplified abstract (Kymab Limited)
• A01K2217/15 (No explanation available)
  • Count: 1 patents
  • Example: 20240057572. Animal Models and Therapeutic Molecules simplified abstract (Kymab Limited)
• A01K2217/075 (No explanation available)
  • Count: 1 patents
  • Example: 20240057572. Animal Models and Therapeutic Molecules simplified abstract (Kymab Limited)
• C12N15/8509 (No explanation available)
  • Count: 1 patents
  • Example: 20240057572. Animal Models and Therapeutic Molecules simplified abstract (Kymab Limited)
• C07K16/462 (No explanation available)
  • Count: 1 patents
  • Example: 20240057572. Animal Models and Therapeutic Molecules simplified abstract (Kymab Limited)

Top Inventors

• Richard Charles Alfred SAINSON (2 patents)
• Volker GERMASCHEWSKI (2 patents)
• Ian KIRBY (2 patents)
• Miha KOSMAC (2 patents)
• Martina RAUNER (2 patents)
• Uwe PLATZBECKER (2 patents)
• Ulrike BASCHANT (2 patents)
• Allan Bradley (2 patents)
• E-Chiang Lee (2 patents)
• Steve HOLMES (2 patents)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors